{2-{4-[5-Cyanomethoxy-4-(5-hydroxy-2-methoxy-4-methyl-benzyl)-2-methoxy-benzyl]-5-hydroxy-2-methoxy-benzyl}-5-[4-(2-cyanomethoxy-5-methoxy-benzyl)-2-hydroxy-5-methoxy-benzyl]-4-methoxy-phenoxy}-acetonitrile | 195602-02-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: {2-{4-[5-Cyanomethoxy-4-(5-hydroxy-2-methoxy-4-methyl-benzyl)-2-methoxy-benzyl]-5-hydroxy-2-methoxy-benzyl}-5-[4-(2-cyanomethoxy-5-methoxy-benzyl)-2-hydroxy-5-methoxy-benzyl]-4-methoxy-phenoxy}-acetonitrile
• 英文别名: 2-[2-[[4-[[5-(Cyanomethoxy)-4-[[4-[[5-(cyanomethoxy)-4-[(5-hydroxy-2-methoxy-4-methylphenyl)methyl]-2-methoxyphenyl]methyl]-5-hydroxy-2-methoxyphenyl]methyl]-2-methoxyphenyl]methyl]-5-hydroxy-2-methoxyphenyl]methyl]-4-methoxyphenoxy]acetonitrile
• CAS: 195602-02-9
• 化学式: C₅₄H₅₃N₃O₁₂
• 分子量: 936.028
• InChiKey: KRNSPCYVTKUTCJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.9
• 重原子数：
  69
• 可旋转键数：
  22
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  215
• 氢给体数：
  3
• 氢受体数：
  15

反应信息

• 作为反应物：
  描述：

  1-碘己烷 、 {2-{4-[5-Cyanomethoxy-4-(5-hydroxy-2-methoxy-4-methyl-benzyl)-2-methoxy-benzyl]-5-hydroxy-2-methoxy-benzyl}-5-[4-(2-cyanomethoxy-5-methoxy-benzyl)-2-hydroxy-5-methoxy-benzyl]-4-methoxy-phenoxy}-acetonitrile 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 [5-(4-{2-Cyanomethoxy-4-[4-(2-cyanomethoxy-5-methoxy-benzyl)-2-hexyloxy-5-methoxy-benzyl]-5-methoxy-benzyl}-2-hexyloxy-5-methoxy-benzyl)-2-(5-hexyloxy-2-methoxy-4-methyl-benzyl)-4-methoxy-phenoxy]-acetonitrile
  参考文献：
  名称：

  Anionic- and Lipophilic-Mediated Surface Binding Inhibitors of Human Leukocyte Elastase

  摘要：

  We report the synthesis of a series of diphenylmethane-based oligomers containing anionic and lipophilic functionalities that are potent inhibitors of human leukocyte elastase (HLE). The enzyme inhibition is regulated by the size of the oligomer, as well as, the number of charges. Lipophilicity is an important element in determining potency and specificity against other basic enzymes. Compounds whose scaffolds contain three phenoxyacetic acid groups and three alkyl ethers are competitive and specific inhibitors of HLE with K-i 20 nM. The mechanism of action of this class of compounds is believed to involve multidendate interactions with the surface of HLE near the active site which prevents substrate access to the catalytic site.

  DOI：

  10.1021/jm970251r
• 作为产物：
  描述：

  2-(4-{4-[4-(4-(2-methoxy-4-methyl-5-{[(2-methoxyethoxy)methyl]oxy}benzyl]-2-methoxy-5-[(cyanomethyl)oxy]benzyl)-2-methoxy-5-{[(2-methoxyethoxy)methyl]oxy}benzyl]-2-methoxy-5-[(cyanomethyl)oxy]benzyl}-2-methoxy-5-{[(2-methoxyethoxy)methyl]oxy}benzyl)... 在 4-甲基苯磺酸吡啶 作用下， 以 异丙醇 、 丙酮 为溶剂， 反应 72.0h， 以95%的产率得到{2-{4-[5-Cyanomethoxy-4-(5-hydroxy-2-methoxy-4-methyl-benzyl)-2-methoxy-benzyl]-5-hydroxy-2-methoxy-benzyl}-5-[4-(2-cyanomethoxy-5-methoxy-benzyl)-2-hydroxy-5-methoxy-benzyl]-4-methoxy-phenoxy}-acetonitrile
  参考文献：
  名称：

  Anionic- and Lipophilic-Mediated Surface Binding Inhibitors of Human Leukocyte Elastase

  摘要：

  We report the synthesis of a series of diphenylmethane-based oligomers containing anionic and lipophilic functionalities that are potent inhibitors of human leukocyte elastase (HLE). The enzyme inhibition is regulated by the size of the oligomer, as well as, the number of charges. Lipophilicity is an important element in determining potency and specificity against other basic enzymes. Compounds whose scaffolds contain three phenoxyacetic acid groups and three alkyl ethers are competitive and specific inhibitors of HLE with K-i 20 nM. The mechanism of action of this class of compounds is believed to involve multidendate interactions with the surface of HLE near the active site which prevents substrate access to the catalytic site.

  DOI：

  10.1021/jm970251r

文献信息

• Anionic- and Lipophilic-Mediated Surface Binding Inhibitors of Human Leukocyte Elastase
  作者：John Regan、Daniel McGarry、Joseph Bruno、Daniel Green、Jack Newman、Chin-Yi Hsu、Jane Kline、Jeffrey Barton、Jeffrey Travis、Yong Mi Choi、Francis Volz、Henry Pauls、Richard Harrison、Asher Zilberstein、Shmuel A. Ben-Sasson、Michael Chang

  DOI：10.1021/jm970251r

  日期：1997.10.1

  We report the synthesis of a series of diphenylmethane-based oligomers containing anionic and lipophilic functionalities that are potent inhibitors of human leukocyte elastase (HLE). The enzyme inhibition is regulated by the size of the oligomer, as well as, the number of charges. Lipophilicity is an important element in determining potency and specificity against other basic enzymes. Compounds whose scaffolds contain three phenoxyacetic acid groups and three alkyl ethers are competitive and specific inhibitors of HLE with K-i 20 nM. The mechanism of action of this class of compounds is believed to involve multidendate interactions with the surface of HLE near the active site which prevents substrate access to the catalytic site.